基于简易口服葡萄糖耐量试验的β细胞功能指数对糖尿病前期和2型糖尿病的预测辨别能力:CODAM研究
在CODAM队列(1999-2009)中,基线476人(平均年龄59.2岁,女性38.7%)接受75g口服葡萄糖耐量试验(OGTT),随访7年后416人复查。利用OGTT中血糖、胰岛素和C肽计算21个简易β细胞功能指数,评估其预测糖尿病前期和2型糖尿病的ROC曲线下面积(AUC)。反映早期胰岛素分泌的指数辨别能力最佳,其中ΔCP30/ΔG30(C肽生成指数)表现稳定。
要点
- 预测糖尿病前期时,所有简易β细胞功能指数的ROC AUC均低于70%。
- 预测2型糖尿病时,I30/I0、CP30/CP0、ΔI30/ΔG30、ΔCP30/ΔG30及校正胰岛素反应30分钟的ROC AUC超过70%。
- 在基线非糖尿病患者中,ΔI30/ΔG30、ΔCP30/ΔG30和校正胰岛素反应30分钟的处置指数对2型糖尿病的ROC AUC超过80%。
核心结论
- 反映早期胰岛素分泌的β细胞功能指数最能辨别未来发生糖尿病前期和2型糖尿病的个体。
- 其中ΔCP30/ΔG30(常称为C肽生成指数)表现持续良好。
研究设计与样本
- CODAM研究(1999-2009)纳入基线476人(平均年龄59.2岁,女性38.7%),随访7年后416人。
- 基线通过2小时75g OGTT评估糖代谢状态,并计算21个简易β细胞功能指数。
- 对辨别能力最佳的β细胞功能指数计算处置指数(β细胞功能指数×Matsuda指数),以校正胰岛素抵抗水平。
- 采用受试者工作特征曲线下面积(ROC AUC)评估对糖尿病前期(n=73)和2型糖尿病(基线非糖尿病患者n=60,基线血糖正常者n=18)的预测能力。
主要发现
- 对糖尿病前期(n=73),所有β细胞功能指数的ROC AUC均低于70%。
- 对2型糖尿病,I30/I0、CP30/CP0、ΔI30/ΔG30、ΔCP30/ΔG30及校正胰岛素反应30分钟的ROC AUC超过70%。
- 在基线非糖尿病患者中,处置指数ΔI30/ΔG30、ΔCP30/ΔG30和校正胰岛素反应30分钟对2型糖尿病的ROC AUC超过80%。
- 这些β细胞功能处置指数对2型糖尿病的辨别能力显著优于单独使用Matsuda指数。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIMS/HYPOTHESIS: The hyperglycaemic clamp technique and the frequently sampled IVGTT are unsuitable techniques to assess beta cell function (BCF) in large cohorts. Therefore, the aim of this study was to evaluate the discriminatory ability of simple OGTT-based BCF indices for prediction of prediabetes (meaning impaired fasting glucose and/or impaired glucose tolerance) and type 2 diabetes. METHODS: Glucose metabolism status was assessed by 2 h 75 g OGTT at baseline (n = 476, mean age 59.2 years, 38.7% women) and after 7 years of follow-up (n = 416) in the Cohort on Diabetes and Atherosclerosis Maastricht (CODAM) study (1999-2009). Baseline plasma glucose, insulin and C-peptide values during OGTTs were used to calculate 21 simple indices of BCF. Disposition indices (BCF index × Matsuda index), to compensate for the prevailing level of insulin resistance, were calculated for the BCF indices with the best discriminatory abilities. The discriminatory ability of the BCF indices was estimated by the area under the receiver operating characteristics curve (ROC AUC) with an outcome of incident prediabetes (n = 73) or type 2 diabetes (n = 60 and n = 18 cases, respectively, in individuals who were non-diabetic or had normal glucose metabolism at baseline). RESULTS: For incident prediabetes (n = 73), all ROC AUCs were less than 70%, whereas for incident type 2 diabetes, I30/I0, CP30/CP0, ΔI30/ΔG30, ΔCP30/ΔG30 (where I, CP and G are the plasma concentrations of insulin, C-peptide and glucose, respectively, at the times indicated), and corrected insulin response at 30 min had ROC AUCs over 70%. In at-baseline non-diabetic individuals, disposition indices ΔI30/ΔG30, ΔCP30/ΔG30 and corrected insulin response at 30 min had ROC AUCs of over 80% for incident type 2 diabetes. Moreover, these BCF disposition indices had significantly better discriminatory abilities for incident type 2 diabetes than the Matsuda index alone. CONCLUSIONS/INTERPRETATION: BCF indices reflecting early-phase insulin secretion have the best ability to discriminate individuals who will develop prediabetes and type 2 diabetes. Of these, ΔCP30/ΔG30, often referred to as the C-peptidogenic index, performed consistently well.
引用
- den Biggelaar LJ, Sep SJ, Eussen SJ, et al. Discriminatory ability of simple OGTT-based beta cell function indices for prediction of prediabetes and type 2 diabetes: the CODAM study. Diabetologia. 2016. PMID: 27933333. doi:10.1007/s00125-016-4165-3
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。